Management Team

Jessica Ching, Co-Founder & Chief Executive Officer

Jessica Ching is an industrial designer responsible for product development and the overall direction of Eve Medical. She has worked previously in product development and manufacturing liaison roles for Herman Miller, Umbra and Telus. She is a graduate of OCAD University, and also holds a BA in International Development from McGill University.

Evan Moses, Co-Founder & Chief Operating Officer

Evan Moses is responsible for operations and finance at Eve Medical. Evan is a second-time entrepreneur and has experience in the management and coordination of complex projects with multiple stakeholders. He holds a BA in Political Science and Economics from McGill University and a MArch from the University of Toronto.

Johan Johanesson, Chief Commercial Officer

Johan Johanesson is a marketing executive with experience launching medical devices in new markets globally. He has worked previously as a Global Marketing Manager for Nobel Biocare in Zurich, and as a Business Development Manager for Central and Eastern Europe at Dentsply. Johan began his career in risk assessment at Volvo Fund Management in Sweden and has a degree in Finance.

Thomas Meier, Managing Director (Europe)

Thomas Meier has more than 20 years’ executive and international experience. He is the former Global Head of Market Development for Roche Diabetes Care, and has previously worked for Credit Suisse, Castrol Lubricants, Kambly, Aventis, Sandoz, Disetronic and Roche Diagnostics. Thomas manages Eve Medical’s European office.

Business Advisory Board

Prof. Attila Lorincz, PhD
Prof. Attila Lorincz received a doctorate in genetics from Trinity College, University of Dublin, Ireland. While a research fellow at the University of California, Santa Barbara he was the first to report that yeast cdc28 is a protein kinase and the prototype of the human cell cycle cdk genes (Lorincz and Reed, Nature 1984). His human papillomavirus studies began in collaboration with Nobel Laureate Harald zurHausen and this work produced clones of many novel carcinogenic HPV types. In 1990 Dr Lorincz co-founded Digene Corp. (now QIAGEN Inc.) as Chief Scientific Officer. His research led to the Hybrid Capture (HC) series of tests, HC2 was the first HPV test to be FDA-approved for cervical pre-cancer screening and is widely regarded as the international reference standard. His subsequent research work includes the development of a simple robust HPV test for resource-limited regions and a randomized clinical trial to validate self-sampling as an efficient screening approach to prevent cervical cancer. Read More

Dr. Brent Norton, MD, MBA, ICD.D
Dr. Brent Norton is an accomplished leader in the Life Science industry with significant experience in various capacities as Founder, President, CEO and Director of several successful Life Science companies which achieved market capitalizations ranging from over $150M CDN to just under $1B USD. Dr. Norton founded PreMD inc., a predictive medicine company, completing an IPO and to listings on both Toronto and American Stock Exchanges. Operationally, he successfully led R&D and commercial transactions with AstraZeneca, Atherogenics, Eli Lilly, L’Oreal, Parke Davis/Pfizer, etc., and took its first product through the FDA, to worldwide out-licensing with Johnson & Johnson/McNeil Consumer Healthcare and product launch. Having completed his medical degree at McGill University, Dr. Norton subsequently obtained a Masters of Business Administration at the University of Western Ontario’s Richard Ivey School of Business and is a certified director from the Institute of Corporate Directors. Read More

Roy Sunstrum, MBA
Roy Sunstrum has over 20 years of leadership experience in disciplines including manufacturing operations, supply management, and product development. He was a key member of the DNA Genotek leadership team (acquired by Orasure 2011), where he held positions including VP Operations and VP Research & Development. Mr. Sunstrum previously held Director & VP level positions at Nortel Networks and JDS Uniphase and presently works with a number of emerging companies to solve execution challenges and enable sustainable growth. He is a member of the advisory board of the Ontario Centers of Excellence Advanced Manufacturing Sector.

Clinical Advisory Board

Dr. Charlotte Gaydos, DrPH, MPH, MS
Dr. Charlotte Gaydos is a Professor in the Division of Infectious Diseases at the Johns Hopkins University School of Medicine. She has joint appointments in the Emergency Medicine Department and at the Johns Hopkins School of Public Health, and is the director of the International Sexually Transmitted Diseases Research Laboratory. She has extensive laboratory expertise with over 40 years experience in microbiology. Dr. Gaydos runs, a program to reduce STI-related infertility through internet-enabled testing.

Dr. Diane Harper, MD, MPH, MS
Dr. Diane Harper is internationally known researcher, clinician and educator in the field of HPV associated diseases, especially focused on the prevention of cervical cancer. She is the Director of the Gynecologic Cancer Prevention Research Group and is a Professor at the University of Missouri Kansas City School of Medicine. Dr. Harper has conducted research on barriers to screening and on HPV self-sampling and was a principal investigator for the clinical trials of both HPV vaccines, Cervarix and Gardasil.

Eve Medical Partners & Supporters


Eve Medical is always looking to connect with individuals, groups, companies and institutions who are interested in improving women’s health. If you’d like to get in touch with us to learn more or to help us in our mission, drop us a line!

Connect With Us
Recent News
OCE Blog Guest Post: Why I Picked Entrepreneurship
Eve Medical will be attending HPV 2012 in San Juan, November 30 – December 6, 2012
Join us at the University of Toronto’s Students for Technology and Engineering in Medicine (STEM)’s first event!
Ontario Centres of Excellence Annual Report Cover Pictures Jessica Ching with fellow Walmsley Recipients